<?xml version="1.0" encoding="UTF-8"?>
<p>Remdesivir is a novel nucleotide analogue currently under evaluation in clinical trials for Ebola infection. Remdesevir has shown clinical an excellent activity against other coronavirus infections (SARS, MERS) both in-vitro and in animal models.</p>
